Pharmaceutical Supply Chain Vision Study


Zebra empowers the front line of business in manufacturing, transportation and logistics, healthcare, retail, and other industries to achieve a performance edge. They deliver industry-tailored, end-to-end solutions that intelligently connect people, assets and data to help their customers make business-critical decisions. Technology-led Transparency Drives Resiliency Rising consumer expectations and industry requirements have precipitated supply chain improvements for new levels of agility, visibility and safety.

Health of the Global Pharmaceutical Supply Chain

The COVID-19 pandemic upended businesses across nearly every category, profoundly altering how society does everything from going to work and school, shopping, getting medical care, and more. The pandemic also exposed vulnerabilities in the global pharmaceutical supply chain. Retailers, healthcare providers and consumers alike shared concerns about potential drug shortages, quality issues and price volatility from the pharmaceutical sector as the world’s focus intensified on healthcare. Pharmaceutical enterprises—including manufacturers, transportation and logistics providers, and healthcare organizations—recognize the potential consequences of an inadequate supply chain and the importance of agility and resiliency. At the same time, each party in the supply chain grapples with the best manner to meet continually rising regulations from governments and industry agencies. Businesses are increasingly embracing technology to enhance quality, traceability and adherence to regulatory requirements. Industry leaders agree that technology holds great promise in helping them safeguard operations against future disruptions or new regulations, avoid or eliminate fines and chargebacks for medications, and ultimately better protect patients.

In a sector where quality and efficacy are paramount, investment in enterprise technology supports the achievement of regulatory compliance as well as patient protection. A culture of data quality and integrity empowers and motivates change for a safer, more agile and more resilient supply chain that can stand up to future market disruptions.

Supply Chain Stability Heightens Patient Satisfaction

Patients and industry decision-makers alike recognize the potential negative consequences of an unstable supply chain. They are aligned in their respective perceptions of the most significant risks posed if the pharmaceutical supply chain is not improved. Medication quality and efficacy due to improper storage, related principally to refrigeration and temperature control, top the list among both segments. Patients also cite perceived risk of illness and possible death due to contaminated, tainted, falsified or counterfeit medications making their way into the supply chain.

Issues with Prescription Medication Are Common The majority of patients surveyed report experiencing issues in the past with either purchasing or taking a prescription medication. Out of stocks and availability issues remain a crucial factor for patients in determining their overall satisfaction; this sentiment mirrors some of the major pain points also experienced in the retail sector in general.

Technology Investment Drives Supply Chain Resiliency

Forward-thinking pharmaceutical-sector enterprises are harnessing the benefits of technology to improve operations and better protect patient health. Spending on enterprise devices and solutions is expected to increase, with a focus on pharmaceutical manufacturing and supply chain monitoring tools. Enhanced visibility is key to an agile and efficient supply chain. Location solutions, such as Radio Frequency Identification (RFID) and Real-Time Location Systems (RTLS), automatically sense the status of assets and inventory to provide real-time visibility across the facility. For pharmaceutical manufacturers and distributors, this can streamline production workflows and help to avoid shrink due to lost or potentially compromised products. Interestingly, 76% of industry decision-makers say that they have already deployed location services technology or plan to in the next year.

Enabling a Safe, Stable and Reliable Supply Chain

Recent years have posed unprecedented challenges to global pharmaceutical supply chains. Despite disruptions, however, protecting the stability, security, quality and efficacy of medications and treatments remains the highest priority. To do so, and to protect patients and their business from the impact of future crises, requires a shift to more predictive and responsive operations. Supply chain resiliency is on the horizon as more industry decision-makers are investing in track and trace technology to enable end-to-end visibility, streamline operations and achieve compliance.

Pharma Supply Chain and Logistics Innovation Programme 2022

Pharma Supply Chain and Logistics Innovation programme is a promising conference of World BI focusing on different aspects of supply chain challenges especially during the COVID-19 pandemic. Get to know how supply chain professionals ensure the agility and visibility of the complex supply chains with the technological advancements in the world nowadays. Implement the robust supply chain plans as forecasted and monitoring the distribution network, keeping in mind the last mile delivery and patient centricity.

7th Pharma Supply Chain and Logistics Innovation Programme to be held in Basel, Switzerland on 10-11 May 2022.

8th Pharma Supply Chain and Logistics innovation Programme to be held in Munich, Germany on 23-24 November 2022.

This year Pharma Supply Chain and Logistics Innovation programme will come up with new flavors discussing all the challenges for a disrupted supply chain post covid, supply chain management and supply chain differentiation covering technological advancements. This conference is a blend of discussions featuring end-end supply chain, supply chain optimization, product security & authentication and regulatory compliance. Speakers & Delegates from MSD, GSK, Novo Nordisk, Vifor Pharma, Bayer, Johnson and Johnson, Novartis, Cytvia, Clover Biopharma and many more are looking forward to joining this conference

Register with us to learn more!